Related Experiment Videos
A commentary on the "consensus statement" regarding the use of BIAsp30
1Sportology Center, Juntendo University Graduate School of Medicine,Tokyo, Japan.
Journal of Diabetes Investigation
|May 21, 2014
Summary
This study discusses intensifying insulin therapy with biphasic insulin aspart-30 (BIAsp30). It emphasizes tailoring treatment to individual diabetes mellitus patients rather than solely relying on consensus recommendations.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacotherapy
Background:
- A recent consensus statement recommends intensifying insulin therapy using biphasic insulin aspart-30 (BIAsp30).
- This statement offers simplified criteria for initiating BIAsp30 therapy.
Purpose of the Study:
- To evaluate the consensus statement on intensifying insulin therapy with BIAsp30.
- To highlight the importance of individualized treatment selection for diabetes mellitus management.
Main Methods:
- Review and critical analysis of the consensus statement on BIAsp30.
- Consideration of the pathophysiological diversity of diabetes mellitus.
Main Results:
- The consensus statement provides valuable simplified criteria for BIAsp30 use.
- Diabetes mellitus exhibits significant pathophysiological heterogeneity.
Conclusions:
- Physicians should prioritize individualized insulin therapy intensification strategies.
- Uncritical adherence to BIAsp30 recommendations may not be optimal for all diabetes mellitus patients.